Study guide

17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

EDAIC Part I European Diploma in Anaesthesiology and Intensive Care

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: The EDAIC Part I Examination

1.1 EDAIC Part I Exam Format, Scoring and Multiple True/False Strategy

2 Chapter 2: Anatomy for Anaesthesia and Intensive Care

2.1 Functional Anatomy of the Upper Airway, Larynx, and Tracheobronchial Tree 2.2 Neuraxial Anatomy: Spine, Spinal Cord, Meninges, and Spaces 2.3 Vascular Anatomy for Central and Peripheral Cannulation 2.4 Peripheral Nerve Plexuses and Autonomic Nervous System Pathways 2.5 Thoracic Anatomy: Chest Wall, Intercostal Spaces, Pleura, Mediastinum and Heart

3 Chapter 3: Respiratory and Cardiovascular Physiology

3.1 Respiratory Mechanics, Lung Volumes, and Work of Breathing 3.2 Ventilation-Perfusion Relationships, Shunt, and Gas Exchange 3.3 Control of Breathing, Hypoxia, Altitude and Hyperbaric Physiology 3.4 Cardiac Cycle, Electrophysiology, and Ventricular Function 3.5 Vascular Resistance, Microcirculation, and Systemic Hemodynamics

4 Chapter 4: Neurophysiology, Renal, Hepatic and Acid-Base Physiology

4.1 Cerebral Blood Flow, Intracranial Pressure, and CSF Dynamics 4.2 Renal Physiology, Glomerular Filtration, and Tubular Transport 4.3 Hepatic Blood Flow, Metabolism, and Clearance 4.4 Acid-Base Regulation, Buffering Systems, and Stewart Approach

5 Chapter 5: Endocrine and Haematological Physiology

5.1 Endocrine Physiology and the Neuroendocrine Stress Response 5.2 Haemostasis Physiology, Coagulation Testing and Inherited Bleeding Disorders

6 Chapter 6: Special Patient Physiology: Maternal, Paediatric and Geriatric

6.1 Maternal Physiological Adaptations to Pregnancy and Uteroplacental Flow 6.2 Neonatal and Paediatric Physiological Differences 6.3 Physiological Changes of Ageing and Thermoregulation

7 Chapter 7: General Pharmacological Principles and Inhalational Anaesthetics

7.1 Pharmacokinetic Principles, Compartmental Models, and Clearance 7.2 Pharmacodynamic Mechanisms, Receptor Theory, and Drug Interactions 7.3 Physical Properties, Uptake, and Distribution of Volatile Anaesthetics 7.4 Minimum Alveolar Concentration (MAC), Organ Effects, and Toxicity

8 Chapter 8: Intravenous Agents, Neuromuscular Blockade and Analgesics

8.1 Intravenous Induction Agents: Propofol, Etomidate, Ketamine, and Barbiturates 8.2 Neuromuscular Blocking Agents: Depolarizing and Non-Depolarizing Drugs 8.3 Neuromuscular Monitoring and Reversal: Anticholinesterases and Sugammadex 8.4 Opioid Pharmacology, Receptors, and Non-Opioid Analgesic Agents

9 Chapter 9: Cardiovascular Drugs, Autonomic Pharmacology and Local Anaesthetics

9.1 Inotropes, Vasopressors, and Inodilators in Perioperative Care 9.2 Antiarrhythmic, Antihypertensive, and Beta-Adrenergic Antagonist Drugs 9.3 Local Anaesthetic Pharmacology, Toxicity (LAST), and Lipid Emulsion Therapy

10 Chapter 10: Haematological and Internal Medicine Pharmacology

10.1 Anticoagulant, Antiplatelet and Haemostatic Drugs and Their Reversal 10.2 Internal Medicine Drugs: Endocrine, Respiratory, Psychiatric and Antiepileptic Agents and Their Anaesthetic Interactions

11 Chapter 11: Physics, Clinical Measurement and Medical Equipment

11.1 Physical Gas Laws, Fluid Dynamics, and Resistance Principles 11.2 Anaesthetic Machines, Gas Supply Pipelines, Cylinders, and Safety Mechanisms 11.3 Breathing Systems, Vaporizer Mechanics, and Scavenging Systems 11.4 Invasive and Non-Invasive Hemodynamic and Respiratory Monitoring

12 Chapter 12: Electrical Safety, Temperature, Humidity and Gas Analysis

12.1 Electricity, Electrical Safety, Diathermy, Defibrillation, Implanted Devices and Fire 12.2 Temperature Measurement, Humidity, Gas Analysis and SI Units

13 Chapter 13: Biostatistics, Clinical Trials and Evidence Appraisal

13.1 Descriptive Statistics, Distributions, and Parametric vs Non-Parametric Tests 13.2 Hypothesis Testing, Power, Type I/II Errors, and Confidence Intervals 13.3 Clinical Study Designs, Bias, and Diagnostic Test Performance (Sensitivity, Specificity, ROC)

14 Chapter 14: General Anaesthesia, Preoperative Evaluation and Airway Management

14.1 Preoperative Risk Assessment, Cardiovascular Risk Indices, and Fasting Guidelines 14.2 The Difficult Airway: Assessment, Algorithms, and Rescue Oxygenation 14.3 Intraoperative Fluid Therapy, Goal-Directed Hemodynamics, and Blood Conservation 14.4 Post-Anaesthesia Care Unit (PACU) Management, Emergence, and Postoperative Nausea/Vomiting

15 Chapter 15: Coexisting Disease and Preoperative Investigations

15.1 Interpreting Investigations: ECG, Chest Radiograph, Lung Function and Blood Tests 15.2 Coexisting Disease I: Asthma, COPD, Obstructive Sleep Apnoea, Obesity, Liver and Renal Disease 15.3 Endocrine Disease and Emergencies: Diabetes, DKA and HHS, Thyroid, Adrenal, Phaeochromocytoma and Carcinoid 15.4 Coexisting Disease II: Neuromuscular and Neurological Disease

16 Chapter 16: Subspecialty Anaesthesia: Cardiothoracic, Vascular and Neuroanaesthesia

16.1 Anaesthesia for Cardiac Surgery and Cardiopulmonary Bypass Management 16.2 Thoracic Anaesthesia, One-Lung Ventilation, and Major Vascular Surgery 16.3 Neuroanaesthesia: Craniotomy, Sitting Position, and Traumatic Brain Injury

17 Chapter 17: Obstetric, Paediatric and Ambulatory Anaesthesia

17.1 Obstetric Analgesia and Anaesthesia: Labour, Caesarean Delivery, and High-Risk Conditions 17.2 Paediatric Anaesthesia: Induction, Airway Management, and Emergencies 17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

18 Chapter 18: Anaesthetic Complications and Specialty Settings

18.1 Anaesthetic Complications: Accidental Awareness, Aspiration, Positioning Injuries, Visual Loss and Dental Damage 18.2 Anaesthesia for ENT and Laser Airway Surgery, Ophthalmic Surgery, and Laparoscopic and Robotic Surgery

19 Chapter 19: Regional Anaesthesia and Acute/Chronic Pain Management

19.1 Neuraxial Techniques: Spinal, Epidural, and Caudal Anaesthesia 19.2 Upper and Lower Limb Peripheral Nerve and Fascial Plane Blocks 19.3 Multimodal Acute Postoperative Pain Management and ERAS Pathways 19.4 Chronic and Neuropathic Pain Syndromes and Interventional Management 19.5 Palliative Symptom Control, Psychological Aspects of Pain and Multidisciplinary Pain Management

20 Chapter 20: Intensive Care Medicine: Ventilation, Shock and Organ Support

20.1 Acute Respiratory Distress Syndrome (ARDS) and Mechanical Ventilation Strategies 20.2 Sepsis-3 Definitions, Septic Shock, and Hemodynamic Resuscitation 20.3 Acute Kidney Injury, Indications for Dialysis, and Continuous Renal Replacement Therapy 20.4 ICU Sedation, Delirium, Weaning, and Brain Death Determination

21 Chapter 21: Intensive Care Medicine: Admission, Nutrition, Infection and Electrolytes

21.1 ICU Admission, Severity Scoring, Nutrition and Routine Prophylaxis 21.2 Antimicrobial Therapy, Stewardship and ICU-Acquired Infections 21.3 Electrolyte Disorders: Sodium, Potassium, Calcium, Magnesium and Phosphate

22 Chapter 22: Intensive Care and Emergency Medicine: Neurocritical Care, Poisoning and Cardiorespiratory Emergencies

22.1 Neurocritical Care: Subarachnoid Haemorrhage, Stroke, Status Epilepticus and Acute Neuromuscular Failure 22.2 Acute Poisoning: Toxidromes, Decontamination and Specific Antidotes 22.3 Acute Cardiorespiratory Emergencies: Pulmonary Embolism, Acute Severe Asthma and COPD, Non-Invasive Support and Acute Heart Failure

23 Chapter 23: Resuscitation, Perioperative Emergencies and Professional Ethics

23.1 Advanced Life Support (ALS) Guidelines and Perioperative Cardiac Arrest 23.2 Perioperative Crises: Malignant Hyperthermia and Severe Anaphylaxis 23.3 Major Trauma, Hemorrhagic Shock, and Massive Transfusion Protocols 23.4 Professional Ethics, Informed Consent, Patient Safety, and Helsinki Declaration

24 Chapter 24: Newborn, Paediatric and Obstetric Emergencies

24.1 Newborn Life Support and Paediatric Life Support 24.2 Obstetric Emergencies: Maternal Collapse, Amniotic Fluid Embolism, Uterine Inversion and Resuscitative Hysterotomy

25 Chapter 25: Burns, Environmental Emergencies and Patient Transport

25.1 Burns, Inhalation Injury, Drowning, Hypothermia, Heat Illness and Decompression Illness 25.2 Prehospital Care and Intra- and Inter-Hospital Transport of the Critically Ill

17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

Key Takeaways Explain This Topic AI

Patient selection for ambulatory surgery evaluates medical stability and functional capacity (stable ASA I-III) rather than arbitrary chronological age or BMI cut-offs, supported by a validated home care environment.

The Post-Anaesthesia Discharge Scoring System (PADSS) requires a cumulative score of >=9 out of 10 across five objective domains (vital signs, ambulation, nausea/vomiting, pain, bleeding), with no zero score permitted.

Frailty (assessed via the Clinical Frailty Scale >=5) is an independent predictor of perioperative mortality, delirium, and loss of independence, carrying greater prognostic value than chronological age alone.

Age-related cardiovascular stiffening and left ventricular diastolic dysfunction create profound dependence on sinus rhythm and atrial kick (supplying 30-40% of ventricular filling) alongside blunted baroreceptor responsiveness.

Postoperative delirium (POD) is an acute, fluctuating disturbance in attention prevented by avoiding deliriogenic medications (benzodiazepines, meperidine, diphenhydramine, centrally-acting anticholinergics) and deploying multi-component non-pharmacological bundles.

Last updated: October 2026

17.3 Ambulatory Day-Surgery Selection, Premedication, and Elderly Patient Anaesthesia

Ambulatory (day-case) surgery has expanded exponentially, encompassing increasingly complex procedures in older, multimorbid patients. Successful day-care pathways require rigorous patient selection, multimodal opioid-sparing protocols, and objective discharge criteria, alongside deep mastery of the physiological senescence and cognitive vulnerabilities of the geriatric surgical cohort.

1. Ambulatory Day-Surgery: Patient Selection, Surgical Criteria, and Social Determinants

Modern day-surgery criteria have shifted away from arbitrary chronological age, isolated BMI cut-offs, or diabetes labels to functional physiological stability and procedure-specific risk stratification.

Patient Selection Criteria

ASA Physical Status:

ASA Class I and II patients are ideal candidates.

Stable ASA Class III patients with medically optimized, non-fluctuating chronic diseases (e.g. well-controlled hypertension, compensated congestive heart failure, stable COPD, medically managed diabetes) are safe for ambulatory surgery provided the surgical procedure does not disrupt chronic physiological homeostasis.

Unstable ASA III or ASA IV patients (e.g. unstable angina, decompensated heart failure, severe pulmonary hypertension) require inpatient admission and post-procedure monitoring.

Obesity and Obstructive Sleep Apnea (OSA):

Elevated BMI alone is not an exclusion criterion. However, patients must be screened for OSA using the STOP-Bang questionnaire (high risk: score ≥ 5 \ge 5 ≥ 5 , or score ≥ 3 \ge 3 ≥ 3 with elevated serum bicarbonate > 28 mmol/L >28\text{ mmol/L} > 28 mmol/L or BMI > 35 kg/m 2 \text{BMI} > 35\text{ kg/m}^2 BMI > 35 kg/m 2 ).

Patients with confirmed or suspected severe OSA can safely undergo ambulatory surgery if: comorbidities are optimized, the surgery is superficial or peripheral, airway management is uncomplicated, multimodal non-opioid analgesia is utilized, and the patient is capable and compliant with using their own continuous positive airway pressure (CPAP) machine in recovery and at home.

Surgical Procedure Criteria

Anticipated operative duration generally < 2 − 3 hours <2 - 3\text{ hours} < 2 − 3 hours .

Negligible risk of massive haemorrhage, major visceral perforation, extensive fluid shifts, or airway compromise.

Postoperative pain must be readily controllable with oral multimodal analgesia or peripheral regional blocks.

Expected low incidence of severe postoperative nausea and vomiting (PONV).

Social and Environmental Determinants

Escort Requirement: A responsible, competent adult must accompany the patient home and remain present for the first 24 hours postoperatively.

Domestic Environment: Access to an indoor telephone, adequate sanitation, and absence of physical environmental hazards (e.g., steep unassisted staircases).

Proximity to Emergency Care: Travel time from the patient's home to an emergency medical facility or surgical center should generally not exceed 60 minutes .

2. Enhanced Recovery After Surgery (ERAS) in Ambulatory Practice

Day-surgery pathways represent the pinnacle of ERAS implementation, optimizing physiological homeostasis to achieve rapid functional recovery. [ AMBULATORY ERAS PATHWAY ]

  • |
  • +---------------------------+---------------------------+
  • | | |
  • [ Preoperative ] [ Intraoperative ] [ Postoperative ]
  • 2h clear fluid fast - Opioid-sparing multimodal - Early oral hydration
  • Carbohydrate loading analgesia (NSAIDs, COX-2) - Prompt ambulation
  • Avoid benzodiazepines - Multimodal PONV prophy- - Discontinue IV lines
  • Patient education laxis (Apfel score) - Verify PADSS score >=9
  • Regional/fascial blocks prior to discharge
  • Core ERAS Elements

Preoperative Optimization & Fasting Guidelines:

Minimize preoperative fasting: clear liquids (water, pulp-free juice, black coffee/tea) allowed up to 2 hours prior to induction; light meals permitted up to 6 hours .

Preoperative Carbohydrate Loading: 400 mL 400\text{ mL} 400 mL of a complex carbohydrate drink 2 hours before surgery attenuates surgical-stress-induced insulin resistance, maintains glycogen stores, and mitigates preoperative thirst, anxiety, and nausea.

Avoidance of Sedative Premedication: Routine administration of long-acting benzodiazepines (e.g. diazepam, lorazepam) is avoided; it delays psychomotor recovery, increases PACU length of stay, and elevates delirium risk.

Intraoperative Strategies:

Multimodal Opioid-Sparing Analgesia: Scheduled paracetamol ( 1 g 1\text{ g} 1 g IV/PO), non-steroidal anti-inflammatory drugs (NSAIDs, e.g. ketorolac, ibuprofen) or COX-2 inhibitors (e.g. parecoxib, celecoxib), combined with surgical local anaesthetic infiltration or ultrasound-guided fascial plane blocks (e.g. TAP, rectus sheath, ESP, adductor canal blocks).

Rational PONV Prophylaxis: Guided by the Apfel risk score (female sex, non-smoker, history of PONV/motion sickness, expected postoperative opioid use; each factor confers ∼ 20 % \sim 20\% ∼ 20% incremental risk). High-risk patients receive multimodal combination therapy: IV dexamethasone ( 4 − 8 mg 4 - 8\text{ mg} 4 − 8 mg at induction), a 5 -HT 3 5\text{-HT}_3 5 -HT 3 ​ antagonist (ondansetron 4 mg 4\text{ mg} 4 mg at emergence), droperidol ( 0.625 − 1.25 mg 0.625 - 1.25\text{ mg} 0.625 − 1.25 mg ), and consideration of total intravenous anaesthesia (TIVA) with propofol.

Postoperative Recovery: Early oral fluid intake, rapid discontinuation of intravenous infusions, and immediate mobilization within 1 to 2 hours.

3. Post-Anaesthesia Discharge Scoring System (PADSS)

The Post-Anaesthesia Discharge Scoring System (PADSS) provides a validated, objective framework for assessing patient readiness for home discharge.

Evaluation Domain Clinical Criteria & Scoring Definition

1. Vital Signs 2: Blood pressure and pulse within ± 20 % \pm 20\% ± 20% of baseline pre-op values; 1: Blood pressure and pulse within ± 20 − 40 % \pm 20 - 40\% ± 20 − 40% of baseline pre-op values; 0: Blood pressure and pulse deviate > 40 % >40\% > 40% from baseline values

2. Activity & Ambulation 2: Steady gait, no dizziness, oriented to time and place (or returned to baseline); 1: Requires assistance to stand or walk; mild dizziness; 0: Unable to ambulate; severe dizziness, marked somnolence, or confusion

3. Nausea and Vomiting 2: Minimal; successfully managed with oral fluids or no medications needed; 1: Moderate; controlled with repeat parenteral antiemetics; nausea persists; 0: Severe; persistent nausea and retching refractory to antiemetics

4. Pain Control 2: Minimal to mild; acceptable to patient; fully managed with oral analgesics; 1: Moderate; requires repeated intravenous rescue analgesics; 0: Severe; persistent intractable pain uncontrolled by available analgesics

5. Surgical Bleeding 2: Minimal; consistent with expected surgical oozing; no dressing change required; 1: Moderate; requires up to two dressing reinforcements; 0: Severe; continuous active bleeding requiring surgical re-exploration

Discharge Criteria and Modern Practice Updates

Threshold Score: A cumulative score of ≥ 9 \ge 9 ≥ 9 out of 10 is required for home discharge.

Veto Rule: No individual category may receive a score of 0 .

Modern Revision on Mandatory Voiding and Drinking: Historical mandates that all day-surgery patients must void urine and tolerate oral fluids prior to discharge have been abandoned. Mandatory pre-discharge voiding is now restricted solely to patients at high risk of urinary retention (e.g. following neuraxial anaesthesia, pelvic/perineal/groin surgery, history of benign prostatic hyperplasia or postoperative urinary retention). Enforcing mandatory drinking delays discharge and can provoke vomiting in otherwise comfortable patients.

4. Anaesthesia for the Elderly and Frail Patient: Frailty Assessment

Chronological age is a poor predictor of perioperative risk; biological frailty governs outcomes.

Clinical Concept of Frailty

Frailty is a multidimensional biological syndrome defined by decreased physiological reserve and diminished resistance to stressors across multiple organ systems. It results from cumulative subclinical cellular and physiological decline.

Assessment Tools:

Clinical Frailty Scale (CFS by Rockwood): A 9-point visual and descriptive clinical tool ranging from 1 (Very Fit) to 9 (Terminally Ill). A CFS score ≥ 5 \ge 5 ≥ 5 (mildly frail, moderately frail, severely frail, very severely frail, or terminally ill) identifies clinical frailty.

Fried Frailty Phenotype: Evaluates 5 physical components: unintentional weight loss ( > 4.5 kg >4.5\text{ kg} > 4.5 kg in past year), self-reported exhaustion, low physical activity, slowed walking speed ( > 6 − 7 s >6 - 7\text{ s} > 6 − 7 s for 4.5 m 4.5\text{ m} 4.5 m ), and muscle weakness (diminished grip strength). Meeting ≥ 3 \ge 3 ≥ 3 criteria confirms frailty (1-2 criteria denotes "pre-frail").

Prognostic Impact: Frailty is an independent, powerful predictor of 30-day perioperative mortality, major postoperative morbidity, surgical site infection, institutionalization, failure to rescue, and postoperative delirium.

5. Physiological Senescence and Organ System Vulnerabilities

Ageing is characterized by progressive organ atrophy, structural stiffening, and loss of functional reserve.

Cardiovascular Senescence

Arterial Stiffening: Fragmentation of elastin fibers and cross-linking of collagen in large conduit vessels (aorta and central arteries) reduce arterial compliance, accelerating pulse wave velocity. This produces elevated systolic blood pressure, widened pulse pressure, and increased left ventricular afterload.

Diastolic Dysfunction: Progressive concentric left ventricular hypertrophy (LVH) and impaired active myocardial relaxation shift ventricular filling from early diastole (passive ventricular filling, E wave) to late diastole (active atrial contraction, A wave).

Reliance on "Atrial Kick": In healthy young individuals, atrial contraction accounts for 15 − 20 % 15 - 20\% 15 − 20% of left ventricular end-diastolic volume (LVEDV). In the elderly with stiff, non-compliant ventricles, active atrial contraction provides 30 − 40 % 30 - 40\% 30 − 40% of ventricular filling . Consequently, loss of sinus rhythm (e.g. new-onset atrial fibrillation or junctional rhythm) precipitates sudden, severe hemodynamic collapse and pulmonary oedema.

Blunted Baroreceptor Reflex & β \beta β -Adrenergic Desensitization: Downregulation of cardiac β 1 \beta_1 β 1 ​ -adrenoceptors, decreased intrinsic pacemaker cells in the sinoatrial node, and stiffening of carotid/aortic baroreceptors blunt reflex chronotropic responses. The elderly patient cannot mount compensatory tachycardia in response to vasodilation or hypovolemia, resulting in profound hypotension upon induction. [ CARDIOVASCULAR SENESCENCE ]

  • |
  • +---------------------------+---------------------------+
  • | |
  • [ Arterial Stiffening ] [ Diastolic Dysfunction ]
  • Loss of elastin; increased collagen - Concentric LV hypertrophy
  • Increased pulse wave velocity - Impaired active relaxation
  • Elevated systolic BP; widened PP - Severe reliance on "Atrial Kick"
  • | (supplies 30-40% of LVEDV)
  • +---------------------------+---------------------------+
  • |
  • [ Autonomic Blunting & Downregulated Beta-1 ]
  • Inability to mount compensatory tachycardia
  • Precipitous hypotension on anaesthetic induction
  • Respiratory Senescence

Thoracic & Lung Mechanics: Calcification of costochondral junctions and progressive kyphoscoliosis reduce chest wall compliance. Concurrently, loss of pulmonary elastic recoil ("senile emphysema") increases lung parenchymal compliance and air trapping.

Closing Capacity ( C C CC CC ) Elevation: Loss of alveolar tethering forces dynamic small airway closure at higher lung volumes. While in young adults closing capacity lies well below functional residual capacity ( F R C FRC FRC ):

At age 44: Closing capacity equals FRC in the supine position ( C C ≥ F R C CC \ge FRC CC ≥ FRC ).

At age 65: Closing capacity equals or exceeds FRC even in the upright sitting position ( C C ≥ F R C CC \ge FRC CC ≥ FRC ).

Clinical Impact: In the supine position under general anaesthesia (which reduces FRC by an additional 15 − 20 % 15 - 20\% 15 − 20% ), tidal ventilation occurs below closing capacity, precipitating widespread airway collapse, alveolar atelectasis, severe ventilation-perfusion ( V / Q V/Q V / Q ) mismatch, and rapid arterial hypoxemia during apnea.

Blunted Ventilatory Drive: Ventilatory responsiveness to hypoxemia is decreased by ∼ 50 % \sim 50\% ∼ 50% , and responsiveness to hypercapnia is diminished by ∼ 40 % \sim 40\% ∼ 40% , amplifying vulnerability to opioid-induced respiratory depression.

Renal and Hepatic Senescence

Renal Reserve: Glomerular filtration rate ( G F R GFR GFR ) declines by approximately 1 mL/min/1.73 m 2 per year 1\text{ mL/min/1.73 m}^2\text{ per year} 1 mL/min/1.73 m 2 per year after age 40 . Renal cortical mass decreases by up to 30 % 30\% 30% , and tubular concentrating and diluting mechanisms deteriorate. Elderly patients are prone to both volume overload and hypovolemia, and exhibit heightened vulnerability to acute kidney injury (AKI) from nephrotoxic drugs (NSAIDs, ACE inhibitors, IV contrast). Sarcopenia causes reduced baseline creatinine production, so serum creatinine remains deceptively "normal" despite marked reductions in GFR.

Hepatic Clearance: Hepatic parenchymal volume declines by 20 − 40 % 20 - 40\% 20 − 40% , and hepatic blood flow decreases by 30 − 50 % 30 - 50\% 30 − 50% . Phase I cytochrome P450 oxidation, reduction, and hydrolysis reactions are significantly impaired, prolonging the clearance of hepatically metabolized drugs (e.g., opioids, local anaesthetics, benzodiazepines). Phase II conjugation (glucuronidation, sulfation) is relatively preserved.

6. Pharmacological Principles and Dosing Adjustments in Geriatrics

Age-related pharmacokinetic ( P K PK P K ) and pharmacodynamic ( P D PD P D ) transformations mandate deliberate, proactive drug dose reductions.

Pharmacokinetic Alterations

Body Composition: Total body water decreases by 10 − 15 % 10 - 15\% 10 − 15% , lean muscle mass decreases, and body fat percentage increases by 20 − 40 % 20 - 40\% 20 − 40% .

Water-soluble drugs (e.g., neuromuscular blockers, paracetamol) have a smaller initial volume of distribution ( V d V_d V d ​ ), leading to higher initial peak plasma concentrations.

Lipid-soluble drugs (e.g., fentanyl, diazepam, volatile anaesthetics) have an expanded V d V_d V d ​ , resulting in significant tissue accumulation, delayed redistribution, and markedly prolonged elimination half-lives ( t 1 / 2 β t_{1/2\beta} t 1/2 β ​ ).

Prolonged Circulation Time: Reduced cardiac output slows arm-to-brain circulation. The peak clinical onset of intravenous induction agents is noticeably delayed. Repeating boluses prematurely results in massive inadvertent overdosing.

Pharmacodynamic Alterations & Practical Dosing Rules

Intravenous Induction Agents: Sensitivity to propofol and etomidate is markedly increased due to heightened central nervous system receptor responsiveness and reduced central compartment volume. Induction doses must be reduced by 30 % − 50 % 30\% - 50\% 30% − 50% and titrated slowly over 60 to 90 seconds.

Volatile Inhalational Anaesthetics: The Minimum Alveolar Concentration (MAC) of volatile agents decreases by approximately 6 % 6\% 6% per decade of life after age 40 . At 80 years, sevoflurane MAC is ∼ 1.6 % \sim 1.6\% ∼ 1.6% (compared to ∼ 2.0 − 2.1 % \sim 2.0-2.1\% ∼ 2.0 − 2.1% at age 40).

Neuromuscular Blockers: The onset of non-depolarizing agents (e.g. rocuronium, vecuronium) is delayed due to slow circulation, but their duration of clinical action is prolonged up to 2-fold due to diminished hepatic uptake and renal excretion. Quantitative neuromuscular monitoring (Train-of-Four with acceleromyography or electromyography) is mandatory, targeting a TOF ratio > 0.9 >0.9 > 0.9 prior to extubation. Sugammadex provides rapid, complete reversal without the cholinergic/muscarinic side effects of neostigmine.

7. Postoperative Cognitive Disorders: Delirium vs Cognitive Dysfunction

Postoperative neurocognitive disorders represent the most frequent surgical complication in older adults, linked to increased mortality, prolonged hospitalization, and loss of independent living.

Postoperative Delirium (POD) vs Postoperative Cognitive Dysfunction (POCD)

Clinical Domain Postoperative Delirium (POD) Postoperative Cognitive Dysfunction (POCD)

Definition Acute, fluctuating disturbance in attention, awareness, and baseline cognition Subtle, persistent, objective deterioration in memory, executive function, and psychomotor speed

Onset & Timing Acute onset: emerges in PACU or POD 1 to 3; peak on day 2 Insidious: evaluated and diagnosed weeks to months postoperatively (typically at 1 to 3 months)

Course Fluctuating over hours to days; usually transient Static or slowly resolving; persists for months to years; may accelerate conversion to dementia

Diagnostic Tool Clinical bedside screening: Confusion Assessment Method (CAM) or CAM-ICU Formal neuropsychological battery compared with preoperative baseline testing

Clinical Subtypes Hypoactive (lethargic, withdrawn, ~65% of cases; most common and worst prognosis); Hyperactive (agitated, combative, ~10%); Mixed (~25%) No motor subtypes; intellectual and executive dysfunction only

Pathophysiology Acute neuroinflammation, blood-brain barrier disruption, cholinergic deficiency, dopamine excess Persistent neuroinflammation, microglial activation, cerebral microvascular injury, amyloid deposition

Deliriogenic Medications to AVOID (The Beers Criteria)

Benzodiazepines: Lorazepam, diazepam, and midazolam disrupt sleep architecture, inhibit cholinergic transmission, and double the risk of delirium in older adults.

Centrally-Acting Anticholinergics: Scopolamine, atropine, and first-generation antihistamines (diphenhydramine, promethazine) directly block central muscarinic receptors, precipitating delirium.

Meperidine (Pethidine): Strictly contraindicated. Its hepatic metabolite, normeperidine , has a prolonged elimination half-life, induces central neurotoxicity, lowers seizure threshold, and precipitates severe delirium.

Multi-Component Non-Pharmacological Interventions

The Hospital Elder Life Program (HELP) bundle provides the strongest evidence for delirium prevention:

Early Postoperative Mobilization: Out of bed within 24 hours.

Sensory Preservation: Immediate return of spectacles (glasses) and hearing aids in the PACU.

Cognitive Reorientation: Clocks, calendars, familiar objects, and family presence.

Sleep Hygiene: Consolidating nocturnal sleep by clustering nursing care, eliminating non-essential nocturnal vitals checks, dimming lights, and minimizing monitor alarms.

Hydration and Pain Control: Maintaining euvolemia and providing opioid-sparing multimodal analgesia.

8. Regional vs General Anaesthesia in the Frail Geriatric Cohort

Evidence from Large-Scale Randomized Trials: The REGAIN trial ( NEJM 2021; 1,600 patients) found no difference between spinal and general anaesthesia in death or inability to walk independently at 60 days after hip fracture surgery, and the RAGA trial ( JAMA 2022; 950 patients) found no difference in postoperative delirium.

Advantages of Regional Techniques: Spinal anaesthesia or peripheral nerve blocks (e.g. femoral nerve block, fascia iliaca compartment block, PENG block) provide superior early postoperative dynamic analgesia, significantly reduce systemic opioid requirements, reduce early postoperative nausea/vomiting, and lower the incidence of immediate PACU respiratory depression.

Hemodynamic Management Under Spinal Anaesthesia: Because elderly patients have non-compliant left ventricles and fixed stroke volumes, sudden sympathetic block-induced vasodilation can precipitate profound coronary and cerebral hypoperfusion. Spinal anaesthesia must utilize low-dose local anaesthetic techniques (e.g. hyperbaric bupivacaine 5 − 7.5 mg 5 - 7.5\text{ mg} 5 − 7.5 mg ) accompanied by proactive prophylactic vasopressor infusions (phenylephrine or low-dose norepinephrine) titrated to maintain mean arterial pressure within 10 − 20 % 10 - 20\% 10 − 20% of baseline.